ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,951Medicare Part D Prescriptions Filled, Including Refills

Rank: 302 out of 1844

$527K Total Retail Price of All Prescriptions

Rank: 315 out of 1844

232 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
69% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 232 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

23% of this provider’s 232 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 8,365 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
WARFARIN SODIUM 451 451 1 13
LEVOTHYROXINE SODIUM 329 313 2 1
FUROSEMIDE 324 324 3 7
HYDROCODONE-ACETAMINOPHEN 291 237 S3 4 2
NAMENDA 242 242 5 33
AMLODIPINE BESYLATE 216 212 6 6
POTASSIUM CHLORIDE 209 205 7 16
SIMVASTATIN 190 186 8 3
METOPROLOL TARTRATE 178 178 9 11
DONEPEZIL HCL 173 173 10 26
OMEPRAZOLE 170 159 11 5
LISINOPRIL 170 170 11 4
CITALOPRAM HBR 166 166 13 19
ACETAMINOPHEN-CODEINE 141 103 S3 14 143
ISOSORBIDE MONONITRATE ER 122 122 15 59
DIGOXIN 120 120 16 67
ESCITALOPRAM OXALATE 116 113 17 52
QUETIAPINE FUMARATE 112 112 18 82
ALLOPURINOL 109 97 19 29
FAMOTIDINE 109 109 19 63
TRAMADOL HCL 98 90 21 18
POLYETHYLENE GLYCOL 3350 95 90 22 39
CYMBALTA 88 88 23 36
ATORVASTATIN CALCIUM 87 77 24 12
NEXIUM 86 80 25 31
SERTRALINE HCL 82 71 26 21
ZOLPIDEM TARTRATE 81 68 27 23
GLIMEPIRIDE 79 64 28 35
ATENOLOL 78 65 29 17
HYDROCHLOROTHIAZIDE 74 63 30 9
ENALAPRIL MALEATE 73 65 31 69
TRAZODONE HCL 73 73 31 43
METFORMIN HCL 70 55 33 8
GABAPENTIN 68 68 34 15
PANTOPRAZOLE SODIUM 64 37 35 32
DIVALPROEX SODIUM 64 64 35 74
COUMADIN 63 63 37 175
LEXAPRO 62 60 38 179
LIDODERM 60 59 39 155
METOPROLOL SUCCINATE 60 60 39 14
ALENDRONATE SODIUM 60 60 39 25
CLOPIDOGREL 59 59 42 34
EXELON 58 58 43 112
CIPROFLOXACIN HCL 57 51 44 62
NOVOLIN R 56 53 45 214
RAMIPRIL 55 46 46 116
LANTUS 52 52 47 42
MUPIROCIN 52 41 47 189
NYSTOP 50 43 49 185
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.